Bordetella pertussis adenylate cyclase (AC) toxin-hemolysin (ACT-Hly) can penetrate a variety of eukaryotic cells. Recombinant AC toxoids have therefore been recently used for delivery of CD8(+) T-cell epitopes into antigen-presenting cells in vivo and for induction of protective antiviral, as well as therapeutic antitumor cytotoxic T-cell responses. We have explored the carrier potential of the ACT molecule by insertional mutagenesis scanning for new permissive sites, at which integration of two- to nine-residue-long peptides does not interfere with membrane interaction and translocation of ACT. A model CD8(+) T-cell epitope of ovalbumin was incorporated at 10 of these permissive sites along the toxin molecule, and the capacity of ACT constructs to penetrate into cell cytosol and deliver the epitope into the major histocompatibility complex (MHC) class I antigen processing and presentation pathway was examined. While all six constructs bearing the epitope within the Hly portion of ACT failed to deliver the epitope to the MHC class I molecules, all four toxoids with inserts within different permissive sites in the AC domain efficiently delivered the epitope into this cytosolic pathway, giving rise to stimulation of a specific CD8(+) T-cell hybridoma. The results suggest that, in contrast to the AC domain, the hemolysin moiety of ACT does not reach the cytosolic entry of the MHC class I pathway.

Cellular and Molecular Microbiology Division Institute of Microbiology of the Academy of Sciences of the Czech Republic CZ 142 20 Prague 4 Czech Republic

See more in PubMed

Barry E M, Weiss A A, Ehrmann I E, Gray M C, Hewlett E L, St. Mary Goodwin M. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J Bacteriol. 1991;173:720–726. PubMed PMC

Basar T, Havlíček V, Bezoušková S, Halada P, Hackett M, Šebo P. The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase toxin is crucial for toxin function independently of its acylation status. J Biol Chem. 1999;274:10777–10783. PubMed

Bejerano M, Nisan M, Ludwig A, Goebel W, Hanski E. Characterization of the C-terminal domain essential for toxic activity of adenylate cyclase toxin. Mol Microbiol. 1999;31:381–392. PubMed

Bellalou J, Ladant D, Sakamoto H. Synthesis and secretion of Bordetella pertussis adenylate cyclase as a 200-kilodalton protein. Infect Immun. 1990;58:1195–2000. PubMed PMC

Bellalou J, Sakamoto H, Ladant D, Geoffroy C, Ullmann A. Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect Immun. 1990;58:3242–3247. PubMed PMC

Benz R, Maier E, Ladant D, Ullmann A, Šebo P. Adenylate cyclase toxin (CyaA) of Bordetella pertussis: evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli. J Biol Chem. 1994;269:27231–27239. PubMed

Betsou F, Šebo P, Guiso N. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun. 1993;61:3583–3589. PubMed PMC

Bottomly K, Davis L, Lipsky P. Measurement of human and murine interleukin 2 and interleukin 4. In: Kruisbeck A M, Coligan J E, Margulis D H, Shevach E M, Strober W, editors. Current protocols in immunology. New York, N.Y: Wiley; 1991. p. 6.3.1. PubMed

Confer D L, Eaton J W. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science. 1982;217:948–950. PubMed

Coote J G. Structural and functional relationships among the RTX toxin determinants of Gram-negative bacteria. FEMS Microbiol Rev. 1992;88:137–162. PubMed

Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase toxins carrying a cytotoxic T cell epitope. J Immunol. 1999;162:4157–4162. PubMed

Fayolle C, Šebo P, Ladant D, Ullmann A, Leclerc C. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. J Immunol. 1996;156:4697–4706. PubMed

Glaser P, Ladant D, Sezer O, Pichot F, Ullmann A, Danchin A. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol Microbiol. 1988;2:19–30. PubMed

Gordon V M, Young W W, Jr, Lechler S M, Gray M C, Leppla S H, Hewlett E L. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J Biol Chem. 1989;264:14792–14796. PubMed

Gray M, Szabo G, Otero A, Gray L, Hewlett E. Distinct mechanisms for K+ efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin. J Biol Chem. 1998;273:18260–18267. PubMed

Guermonprez P, Ladant D, Karimova G, Ullmann A, Leclerc C. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J Immunol. 1999;162:1910–1916. PubMed

Hackett M, Guo L, Shabanowitz J, Hunt D F, Hewlett E L. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science. 1994;266:433–435. PubMed

Hackett M, Walker C B, Guo L, Gray M C, Van C S, Ullmann A, Shabanowitz J, Hunt D F, Hewlett E L, Šebo P. Hemolytic, but not cell-invasive activity, of adenylate cyclase toxin is selectively affected by differential fatty-acylation in Escherichia coli. J Biol Chem. 1995;270:20250–20253. PubMed

Hewlett E L, Gray L, Allietta M, Ehrmann I E, Gordon V M, Gray M C. Adenylate cyclase toxin from Bordetella pertussis. Conformational change associated with toxin activity. J Biol Chem. 1991;266:17503–17508. PubMed

Iwaki M, Ullmann A, Šebo P. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin. Mol Microbiol. 1995;17:1015–1024. PubMed

Karttunen J, Sanderson S, Shastri N. Detection of rare antigen-presenting cells by the lacZ T cell activation assay suggests an expression cloning strategy for T cell antigens. Proc Natl Acad Sci USA. 1992;89:6020–6024. PubMed PMC

Ladant D. Interaction of Bordetella pertussis adenylate cyclase with calmodulin: identification of two separated calmodulin-binding domains. J Biol Chem. 1988;263:2612–2618. PubMed

Ladant D, Glaser P, Ullmann A. Insertional mutagenesis of Bordetella pertussis adenylate cyclase. J Biol Chem. 1992;267:2244–2250. PubMed

Ladant D, Michelson S, Sarfati R S, Gilles A-M, Predeleanu R, Bârzu O. Characterization of the calmodulin-binding and of the catalytic domains of Bordetella pertussis adenylate cyclase. J Biol Chem. 1989;264:4015–4020. PubMed

Mackman N, Nicaud J-M, Gray L, Holland I B. Genetical and functional organisation of the Escherichia coli haemolysin determinant 2001. Mol Gen Genet. 1985;201:282–288. PubMed

Mock M, Ullmann A. Calmodulin-activated bacterial adenylate cyclases as virulence factors. Trends Microbiol. 1993;1:187–192. PubMed

Osičková, A., et al. J. Biol. Chem., in press.

Rogel A, Hanski E. Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. Translocation of the toxin across the membrane. J Biol Chem. 1992;267:22599–22605. PubMed

Rogel A, Meller R, Hanski E. Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis. J Biol Chem. 1991;266:3154–3161. PubMed

Rose T, Šebo P, Bellalou J, Ladant D. Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes. J Biol Chem. 1995;270:26370–26376. PubMed

Sakamoto H, Bellalou J, Šebo P, Ladant D. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities. J Biol Chem. 1992;267:13598–13602. PubMed

Sambrook J, Fritsch E F, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press; 1989.

Saron M F, Fayolle C, Šebo P, Ladant D, Ullmann A, Leclerc C. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc Natl Acad Sci USA. 1997;94:3314–3319. PubMed PMC

Šebo P, Fayolle C, d'Andria O, Ladant D, Leclerc C, Ullmann A. Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect Immun. 1995;63:3851–3857. PubMed PMC

Šebo P, Glaser P, Sakamoto H, Ullmann A. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system. Gene. 1991;104:19–24. PubMed

Šebo P, Ladant D. Repeat sequences in the Bordetella pertussis adenylate cyclase toxin can be recognized as alternative carboxy-proximal secretion signals by the Escherichia coli alpha-haemolysin translocator. Mol Microbiol. 1993;9:999–1009. PubMed

Szabo G, Gray M C, Hewlett E L. Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium and polarity-dependent manner. J Biol Chem. 1994;269:22496–22499. PubMed

Tabor S, Richardson C. A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of genes. Proc Natl Acad Sci USA. 1985;82:1074–1078. PubMed PMC

Welch R A. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol. 1991;5:521–528. PubMed

cAMP signaling of Bordetella adenylate cyclase toxin blocks M-CSF triggered upregulation of iron acquisition receptors on differentiating CD14+ monocytes

A conserved tryptophan in the acylated segment of RTX toxins controls their β2 integrin-independent cell penetration

Filamentous Hemagglutinin of Bordetella pertussis Does Not Interact with the β2 Integrin CD11b/CD18

Pertussis toxin suppresses dendritic cell-mediated delivery of B. pertussis into lung-draining lymph nodes

The Fim and FhaB adhesins play a crucial role in nasal cavity infection and Bordetella pertussis transmission in a novel mouse catarrhal infection model

Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins

Bordetella Adenylate Cyclase Toxin Elicits Airway Mucin Secretion through Activation of the cAMP Response Element Binding Protein

Simultaneous Determination of Antibodies to Pertussis Toxin and Adenylate Cyclase Toxin Improves Serological Diagnosis of Pertussis

Binding of Kingella kingae RtxA Toxin Depends on Cell Surface Oligosaccharides, but Not on β2 Integrins

Retargeting from the CR3 to the LFA-1 receptor uncovers the adenylyl cyclase enzyme-translocating segment of Bordetella adenylate cyclase toxin

Acyltransferase-mediated selection of the length of the fatty acyl chain and of the acylation site governs activation of bacterial RTX toxins

Bordetella Adenylate Cyclase Toxin Inhibits Monocyte-to-Macrophage Transition and Dedifferentiates Human Alveolar Macrophages into Monocyte-like Cells

Distinct Spatiotemporal Distribution of Bacterial Toxin-Produced Cellular cAMP Differentially Inhibits Opsonophagocytic Signaling

Rapid Purification of Endotoxin-Free RTX Toxins

Residues 529 to 549 participate in membrane penetration and pore-forming activity of the Bordetella adenylate cyclase toxin

Cytotoxic activity of Kingella kingae RtxA toxin depends on post-translational acylation of lysine residues and cholesterol binding

Bordetella Pertussis Adenylate Cyclase Toxin Does Not Possess a Phospholipase A Activity; Serine 606 and Aspartate 1079 Residues Are Not Involved in Target Cell Delivery of the Adenylyl Cyclase Enzyme Domain

Phospholipase A activity of adenylate cyclase toxin?

Bordetella pertussis Adenylate Cyclase Toxin Disrupts Functional Integrity of Bronchial Epithelial Layers

Structure-Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes